The Foracort Forte Inhaler combines two medications to support individuals with chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It aids in alleviating persistent symptoms, leading to improved ease of breathing. The mechanism of action involves the suppression of specific inflammatory chemical signals, which reduces swelling and facilitates relaxation of airway muscles. It is important to follow your healthcare provider’s instructions regarding the frequency of inhaler use. While some individuals may observe a noticeable improvement within a few days, optimal benefits generally manifest after several weeks of consistent use. Regular usage of this inhaler is essential, even in the absence of noticeable symptoms, as discontinuing the medication may lead to a deterioration of conditions. The Foracort Forte Inhaler is not intended for immediate relief of acute breathing difficulties; in such instances, a rescue inhaler should be utilized. Proper inhalation technique is crucial for maximizing the therapeutic effects of this medicine; ineffective use may hinder its benefits. Common adverse reactions may include headache, nausea, vomiting, abdominal discomfort, and respiratory infections. If any of these effects occur, ongoing communication with a healthcare professional is advised, rather than discontinuing treatment. To mitigate oral side effects, it is recommended to rinse the mouth or brush teeth post-inhalation. There are certain rare but more serious side effects; if there are any concerns, consultation with a healthcare provider is warranted. Individuals with pre-existing kidney or liver conditions should inform their doctor prior to use for appropriate dosage adjustments. Pregnant and breastfeeding individuals are also encouraged to discuss their situation with a doctor before starting this treatment.
-15%

FORACORT FORTE (Formoterol (12mcg) + Budesonide (400mcg))
Original price was: ₹883.10.₹754.00Current price is: ₹754.00.
Add to cart
Buy Now
Reviews
There are no reviews yet.